Emtricitabine (Emtriva) and Ketamine Therapy | Tovani Health
Emtriva (Emtricitabine) (also: FTC (Truvada/Descovy/Biktarvy component)) — NRTI (HIV/HBV; HIV PrEP component)
Verdict at Tovani Health
Fully compatible with KAP.
Emtricitabine and ketamine have no clinically significant interaction. Commonly co-formulated with tenofovir (Truvada, Descovy) for HIV treatment and PrEP; also a component of Biktarvy. Renally cleared, clean interaction profile.
If you take Emtriva regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Emtriva interacts with ketamine
Emtricitabine is a cytidine analog NRTI that inhibits HIV reverse transcriptase. Renally cleared, no CYP metabolism. Same clean profile as tenofovir.
What we do at intake
Continue as prescribed.
Bottom line
Emtricitabine and ketamine have no clinically significant interaction. Commonly co-formulated with tenofovir (Truvada, Descovy) for HIV treatment and PrEP; also a component of Biktarvy. Renally cleared, clean interaction profile.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Emtriva (Emtricitabine) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 22, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.